Arbutus Biopharma Corporation (Nasdaq: ABUS) announced the acceptance of five abstracts, including a late-breaking study, for ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...

Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people ...

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people worldwide are infected with HDV. Currently, there are only a few treatment ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Key Takeaways. Layoffs at the U.S. Centers for Disease Control and Prevention included all 27 staff at the viral hepatitis ...

Hepatitis viruses A to E differ in transmission and severity, ranging from foodborne infections to bloodborne risks. We got ...

Maurice Hilleman was born ear Miles City on the high plains of eastern Montana and attended Montana State. He would grow up to develop vaccines against measles, mumps, chickenpox, pneumonia, ...

Hepatitis A vaccinations could be lagging among men who have sex with men due to a mistrust of medicine, particularly among ...

If liver failure occurs, it can lead to additional symptoms such as: Hepatitis B is an example of a condition that can cause acute and chronic liver inflammation. Acute symptoms may develop soon after ...

An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.